New CEO and generational change in Qufora A/S
May 10th 2021
For the first time since the company’s establishment in 2006, Qufora gets a CEO who does not belong to the group of founders. Lena Ehmsen Lachenmeier is moving from her position as CCO to the position of CEO – where she will focus on a further scaling of the successful company that produces medical aids for bowel problems.
In just 15 years, Qufora has established itself as a significant international player in the market for innovative aids in gastroenterology and urology products. The company, which is headquartered in Allerød, Denmark, is today represented in a large number of international markets with a special focus on the Nordic region, the United Kingdom, Germany, Italy and the Netherlands.
Over the past two years, Qufora has significantly strengthened its earnings – and it is this development that Lena Ehmsen Lachenmeier will continue and strengthen as the new CEO.
“We will strengthen three focus areas in particular over the coming years. Our launches must be maximized through clearer positioning in the market and strengthened communication. We need to get closer to the clinical professionals who handle our products, e.g. through co-creation and a more structured dialogue. Finally, we will expand our European footprint through larger market shares and new regions”, says Lena Ehmsen Lachenmeier.
From production-focused to innovation company
The former CEO, Christian Dorfelt, who is part of the original founding group, will continue in Qufora, where he will work with business development as part of an expanded Executive Management team.
Chairman of the Board of Qufora, Michael Sorth, states:
“With Lena as CEO, we get a strong leader with extensive market experience. She will be able to continue the company’s positive development with a focus on strategic product development, process optimization and clinical weight. In short, we will move from focusing solely on optimizing the product’s function to prioritizing the development of the overall package, including design, training and clinical outcomes. Lena is the right person to lead this process”.
Help to live an active life
The mission of Qufora is the same as in 2006: to design quality solutions that enable people to live a fulfilled life, by relieving their bowel problems. Qufora produces the market’s largest range of Transanal irrigation aids.
Lena Ehmsen Lachenmeier has a master’s degree from Copenhagen Business School plus an MBA from the University of Reading in England. She joined Qufora in 2019 from a position as Vice President of Global Marketing at the German medical device company Amoena. Prior to that, she was employed by the medical device company Coloplast for 19 years. Here, Lachenmeier held several different positions, most recently as Director of Medical Marketing.
For further information, please contact: Michael Sorth, mms@qufora.com – tel. +45 6120 7265
Mission, vision & values
The cornerstones of our business.
Our vision, mission and values are centered around health.
Bowel irrigation
Bowel irrigation – sometimes called transanal irrigation (TAI) or rectal irrigation (RI) has been practiced for many hundreds of years.
Understanding bowel irrigation
Bowel irrigation simply involves instilling warm tap water into the rectum via the anus to help emptying the colon.
Imagine the possibilities
Discover Qufora IrriSedo Flow, a new bowel irrigation system with an innovative way of managing water flow, that is simply intuitive to use and designed to be individual to suit different situations.